Not a good buy right now: trend is bearish (SMA200 > SMA20 > SMA5) and price is below the key pivot (19.101).
Short-term setup is near support (S1 18.27) with RSI_6 ~32.7, so a bounce is possible, but there is no Intellectia buy trigger to prioritize.
With earnings on 2026-02-11 (after hours) and elevated implied volatility, risk/reward for an impatient entry is not favorable without confirmation reclaiming ~19.10–19.93.
Trend: Bearish alignment (SMA_200 > SMA_20 > SMA_5) indicates the path of least resistance is still down.
MACD: Histogram at -0.168 (below 0) and negatively contracting → downside momentum is easing, but not reversed.
RSI: RSI_6 at 32.685 (weak/near-oversold zone) → supports a potential short-term mean reversion, not a confirmed uptrend.
Levels: Pivot 19.101 is the key reclaim level. Near-term support at 18.27 (then 17.757). Resistance at 19.932 then 20.445.
Pattern-based odds: Similar-pattern projection suggests mild upside bias (next day +0.88%, next week +0.42%, next month +1.22%), but magnitude is small versus current downtrend structure.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open Interest Put-Call Ratio at 0.26 is notably call-heavy (bullish skew), suggesting investors are positioned more for upside than downside.
Activity: Option volume is essentially nonexistent today (total volume 1; put volume 0) and volume vs 30D average is very low (0.11) → today’s tape provides little real-time sentiment confirmation.
Volatility: 30D IV 53.06 vs historical vol 33.83 (IV elevated); IV percentile 58.17 → options are pricing meaningful event risk, consistent with upcoming earnings.
Technical Summary
Sell
7
Buy
8
Positive Catalysts
could trigger a sharp repricing if results/guide surprise to the upside.
implies the positioning crowd leans bullish.
Neutral/Negative Catalysts
Technical backdrop is still bearish (moving averages stacked down; price below pivot), increasing the odds of continued weakness if support breaks.
Earnings event risk with elevated IV: if results/guide disappoint, downside could accelerate quickly.
Net income: 26,309,000 (+24.71% YoY) → earnings growth outpacing revenue.
EPS: 0.25 (+31.58% YoY) → solid per-share growth.
Gross margin: 16.8 (down -6.67% YoY) → margin compression is the main negative trend to monitor.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price-target change data was provided in the dataset, so recent Wall Street revisions cannot be verified here.
Wall Street pros (inferred from available fundamentals): strong YoY revenue, net income, and EPS growth.
Wall Street cons (from provided data): gross margin decline and a technically bearish tape into earnings increase near-term downside risk.
Influential/politician activity: No recent congress trading data available; hedge fund and insider trading trends listed as neutral.
Wall Street analysts forecast CXW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CXW is 30 USD with a low forecast of 28 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast CXW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CXW is 30 USD with a low forecast of 28 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 18.630
Low
28
Averages
30
High
32
Current: 18.630
Low
28
Averages
30
High
32
Texas Capital
initiated
$28
AI Analysis
2025-06-30
Reason
Texas Capital
Price Target
$28
AI Analysis
2025-06-30
initiated
Reason
Texas Capital initiated coverage of CoreCivic with a Buy rating and $28 price target.
Texas Capital
Raj Sharma
Buy
initiated
$28
2025-06-30
Reason
Texas Capital
Raj Sharma
Price Target
$28
2025-06-30
initiated
Buy
Reason
As previously reported, Texas Capital analyst Raj Sharma initiated coverage of CoreCivic (CXW) with a Buy rating and $28 price target. Private prisons currently contain less than 8% of the country's prison population, with CoreCivic being the largest owner/operator in the U.S. and largest private-owner of correctional real estate utilized by government agencies in the U.S., the analyst tells investors. While both CoreCivic and peer Geo Group (GEO) are "attractive investments," the investment case for for the former centers on deployment of currently idle incremental prison facilities, as well as potentially winning incremental monitoring and supervision contracts over the next 12 to 24 months, the analyst says. CoreCivic currently has eight idle facilities that could be reopened under "favorable contract terms," the analyst added.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CXW
